SLS·81642T209·US·equity·Healthcare - Biotechnology-13D/G
SLS (SELLAS LIFE SCIENCES GROUP I) is held by 82 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($51.6M), STATE STREET CORP ($35.5M), GEODE CAPITAL MANAGEMENT, LLC ($16.6M). Net institutional sentiment: Bullish.
See how SLS's score breaks down across 4 SEC sources
Showing 1-20 of 90
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer